Mondego Bio

📍 Cantanhede, Portugal👥 3 employees💰 Last funded Sep 2025
Biotechnology Research🌐 mondegobio.com
Website LinkedIn
Headquartered in Portugal’s main biotech park, Biocant, Mondego Bio is developing best-in-class protein tyrosine phosphatase non-receptor type 2 (PTPN2) inhibitors, providing a potential immuno-oncological therapy with an improved safety and tolerability profile.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Portugal
1
Frequently asked questions
Who invested in Mondego Bio?
Mondego Bio has 1 investors on record on gritt.io.
When did Mondego Bio last raise funding?
The most recent investment in Mondego Bio recorded on gritt.io was in September 2025.
What industry is Mondego Bio in?
Mondego Bio operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Mondego Bio based?
Mondego Bio is headquartered in Cantanhede, Portugal.